Lipoprotein Lipase Antikörper
Kurzübersicht für Lipoprotein Lipase Antikörper (ABIN969262)
Target
Alle Lipoprotein Lipase (LPL) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- LPL Antibody
-
Aufreinigung
- Ascitic fluid
-
Immunogen
- Purified recombinant fragment of LPL expressed in E. Coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA: 1/10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides." in: Human mutation, Vol. 30, Issue 1, pp. 49-55, (2009) (PubMed).
: "Higher post-absorptive skeletal muscle LPL activity in African American vs. non-Hispanic White pre-menopausal women." in: Obesity (Silver Spring, Md.), Vol. 16, Issue 1, pp. 199-201, (2008) (PubMed).
-
: "Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides." in: Human mutation, Vol. 30, Issue 1, pp. 49-55, (2009) (PubMed).
-
- Lipoprotein Lipase (LPL)
-
Andere Bezeichnung
- LPL
-
Hintergrund
- LPL: lipoprotein lipase, also known as LIPD, HDLCQ11. Entrez Protein: NP_000228. It is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
-
Molekulargewicht
- 53.1 kDa
-
UniProt
- P06858
-
Pathways
- Lipid Metabolism
Target
-